Reverse micelles prepared from amphiphilic polylactide-b-poly(ethylene glycol) block copolymers for controlled release of hydrophilic drugs.
This work aims to evaluate the potential of reverse micelles prepared from amphiphilic polylactide-b-poly(ethylene glycol) (PLA-b-PEG) block copolymers for controlled release of hydrophilic drugs. Different PLA-b-PEG diblock and triblock copolymers were synthesized by ring-opening polymerization of D- or L-lactide in the presence of a PEG macroinitiator. Reverse micelles were prepared by self-assembly of copolymers in a solvent/co-solvent/water system. Toluene was used as solvent, and ethanol as co-solvent to solubilize appropriate amount of water. The resulting nano-sized reverse micelles were able to encapsulate heparin in the hydrophilic core. Dynamic light scattering (DLS) and transmission electron microscopy (TEM) were used to determine the size and morphology of reverse micelles. The results show that reverse micelles are spherical in shape with sizes below 100 nm. Drug loaded reverse micelles were embedded in biocompatible membranes by mixing with 10% PLA solution in toluene with 1:3 volume ratio. In vitro release studies were realized in phosphate buffer saline (PBS) at 37°C. Heparin was almost totally released within 24h. Triblock copolymer reverse micelles exhibited faster drug release than diblock ones probably due to the more compact micelle structure of the latter. Therefore, PLA-b-PEG reverse micelles could be promising for applications as carrier of hydrophilic drugs when embedded in biocompatible membranes.
European Institute of Membranes, UMR CNRS 5635, University of Montpellier, 34095 Montpellier, France.
Thi Bich Tran
TBT
Nguyen
European Institute of Membranes, UMR CNRS 5635, University of Montpellier, 34095 Montpellier, France. Electronic address: summing.li@umontpellier.fr.
Suming
S
Li
European Institute of Membranes, UMR CNRS 5635, University of Montpellier, 34095 Montpellier, France.
André
A
Deratani
D003692:Delayed-Action Preparations / Q000737:chemistry*; D016503:Drug Delivery Systems; D065546:Drug Liberation; D006493:Heparin / Q000032:analysis / Q000737:chemistry*; D057927:Hydrophobic and Hydrophilic Interactions; D007773:Lactates / Q000737:chemistry*; D008823:Micelles; D011092:Polyethylene Glycols / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry
D003692:Delayed-Action Preparations; D007773:Lactates; D008823:Micelles; D011108:Polymers; C088513:poly(lactic acid-ethylene glycol); D011092:Polyethylene Glycols; D006493:Heparin
Block copolymer; Controlled release; Heparin; Poly(ethylene glycol); Polylactide; Reverse micelles